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107 ml/min/1.73 m 2 up to the age of 40 years, but renal de-
cline begins beyond 40 years. No evidence could be found 
for any difference between men and women in the separate 
age groups.  Conclusions: The current meta-analysis sup-
ports the mathematical form of the FAS equation, which 
matches the age/sex dependency of measured GFR for 
healthy potential living kidney donors. 
 © 2016 S. Karger AG, Basel 
 Introduction 
 Defining normal kidney function is certainly a difficult 
task in nephrology. Indeed, renal function is a vast con-
cept, which can be approached in several different ways. 
Glomerular filtration rate (GFR) is considered as one im-
portant parameter to assess global kidney function  [1, 2] . 
Definition of normal kidney function implies that GFR is 
measured with high precision. However, direct measure-
ment of GFR is not so easy in daily practice and most ne-
phrologists refer to estimated GFR (eGFR), that is, equa-
tions based on biomarkers like serum creatinine (Scr) or 
plasma cystatin C  [3–5] . Another difficulty with GFR is 
the fact that GFR physiologically decreases with aging. In 
other words, the ‘normal’ thresholds of GFR are obvious-
ly different at 40 versus 80 years  [1, 6–8] . Relatively few 
studies have been published where measured GFR 
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 Abstract 
 Background: Normal kidney function or, more specifically, 
normal glomerular filtration rate (GFR) in men and women 
and its decline with age is still much debated today. The 
Chronic Kidney Disease Epidemiology Collaboration (CKD-
EPI) equation has gender (and race) multiplication factors, 
accounts for a decline that starts at very young age and as-
sumes that the mean GFR is as high as 120–130 ml/
min/1.73 m 2 from a young age. The full age spectrum (FAS) 
estimated mean GFR is about 107 ml/min/1.73 m 2 at a young 
age and remains constant until the age of 40 years and then 
starts to decline both in men and women. The aim of this re-
search study was to give more insight into ‘normal’ GFR levels 
and the physiological decrease of kidney function with age 
and to use a meta-analysis to evaluate the mathematical con-
struction of the FAS and the CKD-EPI equation.  Methods: We 
conducted a meta-analysis of published GFR measurements 
in healthy Caucasian living potential kidney donors (n  = 
5,482, 46.8% men). Only publications dating from 2000 were 
selected to avoid the possible influence of body surface area 
changes in the last decades on the indexed GFR, expressed 
in ml/min/1.73 m 2 .  Results: We found that the mean GFR  ≈ 
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(mGFR) has been obtained in healthy subjects and, in vast 
majority of these studies, the samples remain relatively 
modest  [6, 9–20] . We thus believe there is a place for a 
meta-analysis on this topic, focusing on key points which 
remain controversial in the literature: what is ‘normal’ 
GFR? Is ‘normal’ GFR different in men and women? 
When does the physiological decrease in GFR begin? All 
these questions are also of importance to evaluate and 
compare the construction of the recommended Chronic 
Kidney Disease Epidemiology Collaboration (CKD-EPI) 
equation  [4] and the new full age spectrum (FAS) equa-
tion  [21] , which was recently proposed to estimate GFR 
across the entire age spectrum from 2 to old age (FAS-
eGFR = 107.3/(Scr/Q) × 0.988 (age–40) when age >40 years), 
where Q is the median Scr concentration for healthy age-
matched subjects (0.90 mg/dl for men and 0.70 mg/dl for 
women). Indeed, the FAS equation and CKD-EPI equa-
tion clearly differ in mathematical construction. The FAS 
equation implies that (i) mean GFR of healthy subjects 
aged between 18 and 40 years is approximately 107 ml/
min/1.73 m 2 and not decreasing from around 125 (at 18 
years) to 107 ml/min/1.73 m 2 (at 40 years), as predicted 
by CKD-EPI, (ii) GFR is not different in men and women, 
thus, no gender multiplication factor at the GFR level is 
required and (iii) decline in GFR only begins at 40 years 
and not already at the age of 18 years, as built in the math-
ematical construction of the CKD-EPI equation  [21] . 
Moreover, this decline rate is faster in FAS (as expressed 
by 0.988 age ) than in the CKD-EPI equation (as expressed 
by 0.993 age ).
 To answer these much-debated questions, we present a 
meta-analysis summarizing mGFR data from all currently 
available relevant studies in healthy living potential kid-
ney donors, allowing for a more comprehensive under-
standing of the differences between men and women and 
the evolution of mean GFR of healthy subjects with aging.
 Materials and Methods 
 Search Strategy 
 The review article of Delanaye et al.  [1] listed studies of suffi-
cient size and representative of the general population for which 
the healthy status of the sample was unquestionable, and where the 
method used to measure GFR was accurate and the statistical as-
sessment adequate (n = 25;  fig. 1 ). These studies were here identi-
fied for the current meta-analysis. Using the search terms ‘GFR’ 
Records identified by
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and ‘living kidney donors’, we searched PubMed/MEDLINE and 
Web of Science (Web of Knowledge) databases between the year 
2000 up to November 2015 and additionally identified 4 studies 
published after 2012 (the publishing date of the Delanaye review) 
presenting mGFR in living potential kidney donors ( fig. 1 ).
 Two contributing authors (H.P. and P.D.) considered and se-
lected studies as potentially eligible for our meta-analysis by inde-
pendently reviewing the titles and abstracts of each study identified 
by the search and then examining the full text. We resolved any 
disagreement regarding whether a particular study should be in-
cluded using discussion among all of the contributing authors, fol-
lowed by a consensus reached by all.
 Inclusion and Exclusion Criteria 
 Only publications written in English and dating from after the 
year 2000 were selected to avoid the possible influence of body sur-
face area (BSA) changes in the last decades on the indexed GFR, 
expressed in ml/min/1.73 m 2  [9] . Based on that criterion, 13 studies 
were excluded ( fig. 1 ). More recent studies presented lower mGFR 
values as normal compared to prior studies published in the 1950s 
or before. This observation is explained by the BSA adjustment as 
BSA has been increased significantly during the last 3 decades and 
the BSA-unadjusted GFR did not show such a decrease  [9, 22] .
 Only publications involving white and Arabic (Caucasian) liv-
ing potential kidney donors were selected, because it is suspected 
that normal GFR could be different according to ethnicity, espe-
cially in Asian people  [1] . We also excluded abstracts and studies 
that did not allow the retraction of numbers, mean GFRs and SDs 
from the published text. Based on these 2 criteria, 4 studies were 
excluded ( fig. 1 ). Finally, 12 articles were involved in the meta-
analysis ( fig. 1 ). For each article, male and female data were pre-
sented separately, which leads to a maximum of 2 × 12 = 24 ‘stud-
ies’ used in this meta-analysis.
 Outcome Measures 
 We retrieved measured mean GFR (ml/min/1.73 m 2 ), SD, age 
group, sex and numbers of men/women in each age group. SD 
was sometimes obtained from 2.5th or 5th percentile to 95th or 
97.5th percentile, using SD = (Pct2.5–Pct97.5)/4 or SD = (Pct5–
Pct95)/3.29. We defined age groups as decades: 20–30, 30–40, 40–
50, 50–60, 60–70 and  ≥ 70 years, but when case data were not avail-
able from these decades, we shifted by maximum 5 years to match 
the predefined age groups.
 Data Extraction 
 Two contributing authors (H.P. and L.H.) independently ex-
tracted the data from the full text and partitioned the numbers into 
age groups. Any disagreement between the 2 authors was resolved 
by discussion. For the outcomes of GFR, relevant group means 
(SD) per age group were extracted from each included study, by 
inspecting the tables or figures or by reading the text. When mean 
GFR and/or numbers for men and women were not available from 
the tables, we made a reasonable estimate from the figures (for 
mGFR, and by counting subjects, where possible for men and 
women) and tried to assign correct numbers to age groups for 
men/women, as much as possible. In case the numbers for men or 
women were simply not available, neither from tables nor inspec-
tion of figures nor by reading the text, we equally distributed men 
and women among age groups, a subjective decision which we only 
applied in very few cases, as described in  table 1 .
 Statistical Analysis 
 All statistical analyses were performed in MS Excel using a self-
written macro in Visual Basic for Applications (online suppl. ma-
terial; for all online suppl. material, see www.karger.com/
doi/10.1159/000450893), after the theory outlined by Lipsey and 
Wilson  [23] . Continuous outcomes were analyzed using mean dif-
ferences and SDs.
 Effect sizes for the difference between sexes were calculated 
along with 95% CIs using a fixed effect model. We assumed that 
the effect sizes differ only because of sampling error, because we 
rule out the differences between studies by defining the effect size 
as the difference between mGFR for both sexes, divided by the 
pooled SD, and thus the effect size from each study estimates a 
single common mean. Effect sizes differ from each other because 
each study used a different sample of participants.
 A random-effects model was used to determine the overall 
mean mGFR and 95% CIs for the means. A random-effects mod-
el assumes a genuine diversity in the results of the included stud-
ies due to between-study heterogeneity and incorporates a be-
tween-study variance (random effect) into the calculation accord-
ingly.
 Between-study heterogeneity was evaluated using the χ 2 test 
based on the Cochran’s Q statistic, and an I 2 index was used for 
assessing heterogeneity, in which an I 2 value of 25, 50 or 75% rep-
resented low, moderate or high heterogeneity, respectively. p < 
0.05 was considered statistically significant, although correction 
for multiple comparisons is considered during the discussion.
 We also investigated the relationship between the outcome 
mean mGFR and the covariates ‘study’, ‘sex’, ‘age-group’ and 
‘method’ with a weighted generalized linear model (GLM). 
 Results 
 Eligible Studies and Study Characteristics 
 Table 1 gives an overview of the studies and the way we 
obtained mean GFR, SD and numbers for men and wom-
en from the 12 selected publications  [6, 9–16, 24–26] .
 Extracted Data from the Selected Studies 
 Table 2 gives a detailed overview of the data for mean 
GFR, SD and numbers of men and women per age group, 
as we extracted them from these publications. A total of 
5,482 (2,565 men and 2,917 women) living kidney do-
nors, who were subdivided to 104 sub-studies (per age 
group and gender), were involved in this meta-analysis. 
The data from  table 2 were used to answer the research 
questions of interest.
 Is There a Difference between Men and Women in 
Each Age Group? 
 We subdivided each publication into a study for men 
and women as we wanted to evaluate the difference in 
mean GFR between sexes. The results of this fixed-effects 






















   
   
   
   
   
   
   
   
   
   






















(I 2 ) between studies is presented for information only and 
was low to moderate. Up to the age of 50 years, there is no 
difference between men and women (effect sizes are not 
different from zero). Above 50 years, there is a tendency 
for a difference of about 3.5 ml/min/1.73 m 2 , with a faster 
renal decline in women than in men. For the age group 
 ≥ 70 years, only 3 studies had a small number of subjects 
and none of these studies reported mean mGFRs for men 
and women separately.
 What Is the Mean GFR in Each Age Group? 
 To answer this research question, we performed a 
meta-analysis to estimate the mean GFR in the different 
age groups. The results of the random-effects model are 
summarized in  table 4 . Forest plots ( fig. 2–6 ) show the 
mean mGFR with 95% CIs for the mean for each study, 
separate for men and women, together with the final 
mean mGFR (and 95% CI) obtained from the meta-
analysis random-effects model. For each age group, large 
heterogeneity between the studies was observed.  Figures 
2 and  3 also show the mean mGFR  = 107.3 ml/
min/1.73 m 2 (vertical line) predicted from the FAS equa-
tion and the possible CKD-EPI predictions (shaded area) 
for the average healthy adult <40 years (corresponding 
with Scr = 0.90 mg/dl for males and 0.70 mg/dl for fe-
males). When the vertical line crosses the horizontal 
95% CIs, this indicates that there is no statistically sig-
nificant difference between the study results and the 
Table 1. List of studies included in this meta-analysis and description of the methods used to extract the relevant data. The table and 
figure numbering refers to the corresponding reference
Study reference Mean GFR SD Numbers and age-groups
Hamilton et al. [10], 2000 Read from table 3 Read from table 3 Read from table 3
Vervoort et al. [24], 2002 Read from table 2 Read from table 2 Read from table 1. All data were 
for ages (28.2±1.96 × 6.1). M/F 
were equally distributed into 
2 age-groups
Hoang et al. [11], 2003 Read from figure 1 and table 1. Equality 
for M/F reported in the text
Read from table 1 Read from figure 1 and table 1. 
Age-dependence reported in 
table 1 and figure 1
Fehrman-Ekholm and 
Skeppholm [25], 2004
Read from the text Read from the text Read from the text. No difference 
between M/F reported
Rule et al. [12], 2004 From table 1 at midpoints of age-groups Calculated as (Pct97.5–Pct2.5)/4 Read from figure 2
Grewal and Blake [13], 2005 103.4 for age >40 years; 103.4–0.91 × (age – 40) 
for age ≥40 years. No difference between M/F
2 × SD = 28.9 Read from figure 1, respecting 
totals obtained from the text
Berg [14], 2006 From table 3 From table 3 From table 3
Poggio et al. [9], 2009 Read from table 3 at mid-points of age-groups Calculated as (Pct95–Pct5)/3.29 Read from figure 1 and table 2 + 
shifted 5 years
Peters et al. [15], 2012 From table 4 (<30 years and 65+) and figure 4 From table 4 (<30 years and 65+). 
The same SDs are used for the 
other age-groups
From table 4 (<30 years and 65+).
In the text, it is mentioned that 
n = 778/543 women/men are 
aged >40 years
Soares et al. [26], 2013 Read from the text Read from the text Read from figure 1 and totals 
from the text
Blake et al. [6], 2013 103.9–0.0061 × age2 and read from figure 3 2 × SD = 25.8 Determined from table 1 and 
below 50 years allocated as 50% 
(40–50 years), 30% (30–40 years) 
and 20% (20–30 years), based on 
the density of the points in figure 2
Holness et al. [16], 2013 From figure 5 and the text and formula (13) for 
age >40 years: GFR = 170–1.55 × age at 
midpoints
2 × SD = 27.5 below 40 years and 
2 × SD = 36.7 above 40 years
From figure 5 and equally 
distributed between males and 
females
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Table 2.  Data extracted from the selected studies in order of appearance
Study Age, years  Males Females
n mG FR SD n mGFR SD
Hamilton et al. [10], 2000 21–60 130 108 14 42 110 16
51Cr-EDTA 20–30 79 107 14 19 112 18
30–40 32 108 16 12 106 13
40–50 13 109 15 9 108 14
50–60 6 108 12 2 93 12
Vervoort et al. [24], 2002 28.2±6.1 23 104 9 23 109 13
Inulin 20–30 11 104 9 11 109 13
30–40 12 104 9 12 109 13
Hoang et al. [11], 2003 18–88 104 60
Inulin 20–30 55 104 15 21 104 15
30–40 25 104 15 14 104 15
40–50 7 95 15 5 95 15
50–60 3 81 17 8 81 17
60–70 10 81 17 5 81 17
>70 4 81 17 7 81 17
Fehrman-Ekholm and Skeppholm [25], 2004 71–110 32 67.7 10.8 20 67.7 10.8
Iohexol >70 32 67.7 10.8 20 67.7 10.8
Rule et al. [12], 2004 18–71 160 205
Iothalamate 20–30 30 109 13.50 27 109 13.50
30–40 56 104 13.75 55 104 13.75
40–50 41 99 13.75 73 99 13.75
50–60 20 94 13.50 39 94 13.50
60–70 13 89 13.50 11 89 13.50
Grewal and Blake [13], 2005 19–72 210 218
51Cr-EDTA 20–30 33 103.4 14.45 13 103.4 14.45
30–40 76 103.4 14.45 65 103.4 14.45
40–50 44 98.9 14.45 58 98.9 14.45
50–60 44 89.8 14.45 58 89.8 14.45
60–70 13 80.7 14.45 24 80.7 14.45
Berg [14], 2006 21–67 60 105.0 13.00 62 105.0 13.00
Inulin 20–30 12 119 12 12 102 15
30–40 22 104 13 23 110 12
40–50 22 100 11 25 105 11
50–60 4 92 11 2 85 1
Poggio et al. [9], 2009 39±10 411 529
Iothalamate 20–30 58 111 16.72 46 114 16.72
30–40 120 107 16.72 138 111 16.72
40–50 123 103 16.72 165 107 16.72
50–60 85 93 16.72 137 96 16.72
60–70 25 88 17.02 43 91 16.72
Peters et al. [15], 2012 819 1,059
51Cr-EDTA 20–30 105 98.5 13.2 91 100.8 15.4
30–40 171 102.0 13.2 190 97.0 15.4
40–50 245 94.0 13.2 349 92.0 15.4
50–60 245 88.0 13.2 348 82.0 15.4






















   
   
   
   
   
   
   
   
   
   






















mean mGFR of 107.3 ml/min/1.73 m 2 . For subjects >40 
years, the grey-shaded areas in  figures 4–6 indicate the 
areas of possible FAS (or CKD-EPI) predictions for that 
age interval (for the same Scr values). Overlap with the 
95% CIs of the studies indicates no statistically signifi-
cant difference.
 When Does Renal Function Start to Decline? 
 The selected studies for the age groups 20–30 and 30–
40 years were the same, which allowed us to test equality 
of mean GFR between these age groups, controlling for 
study and sex. The overall effect size was 0.12 with 95% CI 
0.03–0.21 (p = 0.012) indicating that there is a slight sta-
Study Age, years  Males Females
n mG FR SD n mGFR SD
Soares et al. [26], 2013 19–70 123 108 18 162 104 18
51Cr–EDTA 20–30 28 113 18 36 111 18
30–40 29 113 18 37 111 18
40–50 28 101 16 37 96 14
50–60 32 101 16 43 96 14
60–70 6 101 16 9 96 14
Blake et al. [6], 2013 18–84 436 468
51Cr–EDTA 20–30 65 104 12.9 63 101 12.9
30–40 98 97 12.9 98 99 12.9
40–50 163 92 12.9 154 93 12.9
50–60 71 89 12.9 108 85 12.9
60–70 37 81 12.9 33 77 12.9
>70 2 70 12.9 12 70 12.9
Holness et al. [16], 2013 18–59 57 107 14.9 69 100.7 17.9
99mTc–DTPA 20–30 21 108.0 13.75 32 108.0 13.75
30–40 15 108.0 13.75 15 108.0 13.75
40–50 17 100.3 18.35 17 100.3 18.35
50–60 4 84.8 18.35 5 84.8 18.35
 n = Number of subjects.
Table 2. (continued)
Table 3.  Meta-analysis results for comparing mean GFR between men and women
Age group, 
years
#Studies #M #F I2 (%; p value) Standardized effect 
size (95% CI)
p value Effect size (95% CI), 
ml/min/1.73 m2
20–30 11/12 497 371 33.1 (0.134) –0.03 (–0.16 to 0.11) 0.714 –0.4 (–2.3 to 1.6)
30–40 11/12 656 659 49.4 (0.032) 0.00 (–0.11 to 0.11) 0.969 0.0 (–1.5 to 1.6)
40–50 10/12 703 892 22.3 (0.238) –0.01 (–0.11 to 0.09) 0.831 –0.1 (–1.6 to 1.3)
50–60 10/12 514 750 50.0 (0.035) 0.23 (0.12 to 0.35) 0.0001 3.4 (1.7 to 5.1)
60–70 7/12 157 206 22.6 (0.257) 0.25 (0.04 to 0.47) 0.020 3.7 (0.6 to 6.9)
>70 3/12 38 39 0.0 (1.000) 0.00 (–0.48 to 0.48) 1.000 0.0 (–6.7 to 6.7)
Total 2,565 2,917
 #Studies = The number of studies or articles involved in the hypothesis of equality (out of 12 selected articles). I2 (p value) = 
measure of homogeneity among studies, with p indicating Cochran’s Q significance. Standardized effect size = difference in mean 
mGFR between males (#M) and females (#F) divided by the pooled SD. 95% CI for the effect size. p = p value for testing the hypo-
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tistically significant but clinically meaningless difference 
of 1.8 ml/min/1.73 m 2 between the mean GFR of both age 
groups; however, when correcting for multiple compari-
sons, this p value turns into a non-significant difference.
 With the only exception of the study by Vervoort et al. 
[24] , all studies for the age groups 30–40 and 40–50 years 
were the same, which allowed us again to test the equality 
of mean GFR between these age groups. The overall effect 
size was 0.39 (95% CI of 0.31–0.47; p < 0.0001) indicating 
that there was a strong statistically significant (and clini-
cally relevant) difference of 5.9 ml/min/1.73 m 2 between 
the mean GFR of both age groups.
 All studies for the age groups 40–50 years were com-
pared with the age groups 50–60 years yielding an overall 
effect size of 0.53 with 95% CI of 0.45–0.61 (p < 0.0001) 
indicating that the decrease accelerates as mean mGFR is 
significantly different (7.8 ml/min/1.73 m 2 ) from the pre-
vious age group with a larger effect size.
 Finally, the comparison between age groups 50–60 and 
60–70 years (for all studies, except for Vervoort et al.  [24] , 
Hamilton et al.  [10] , Berg  [14] and Holness et al.  [16] who 
did not have kidney donors in the last age group) gives an 
overall effect size of 0.55 with 95% CI of 0.42–0.67 
(p  <  0.0001) corresponding to a difference of 8.2 ml/
min/1.73 m 2 indicating that the decrease goes on at the 
same rate.
 Sensitivity Analysis 
 We performed a sensitivity analysis, leaving out one 
study (both men and women) at a time to evaluate the 
influence of one particular study on the overall results. In 
the age groups 20–30, 30–40, 50–60 and 60–70 years, the 
largest influence was obtained from the study of Peters et 
al.  [15] , with a significant decrease in heterogeneity I 2 
when omitted. In the age group of 40–50 years, the study 
of Poggio et al. [9] showed the largest influence, and when 
omitted, heterogeneity I 2   = 90.3% decreased to 82.2%. 
The sensitivity analysis raised the question whether there 
was an effect of the method used.
 Is There an Effect of the Method Used? 
 This question is difficult to answer without the indi-
vidual patient data. However, we realized that most of the 
studies were obtained with  51 Cr-EDTA (50/104 = 48.1%), 
followed by inulin (24/104  = 23.1%), iothalamate 
(20/104 = 19.2%),  99m Tc-DTPA (8/104 = 7.7%) and io-
hexol (2/104 = 1.9%). We performed a fixed-effect analy-
sis in each age group for the  51 Cr-EDTA studies, the inu-
lin studies and the iothalamate studies, pooling studies on 
men and women ( table 5 ).
 The mean GFRs obtained in each age group by  51 Cr-
EDTA are significantly lower than those obtained with 
iothalamate. In 2 age groups,  51 Cr-EDTA is also signifi-
cantly lower than the inulin reference method. The con-
clusion is that there is a significant difference between 
GFR methods with underestimation for  51 Cr-EDTA and 
overestimation of iothalamate compared to the inulin ref-
erence method.
 Meta-Regression 
 A weighted GLM (weights were defined as w i   = 1/
(SD i ²/n i )) explains 99% of the variation in mGFR, with 
‘age group’, ‘study’ and the interaction term ‘age group’ × 
‘study’ explaining, respectively, 50.3, 42.0 and 4.3% of the 
variation in mGFR. This reflects the age decline of mGFR 
and the heterogeneity between the studies at hand. ‘Sex’ 
only explained 0.5% of the total variation and the interac-
tion terms ‘study’ × ‘sex’ and ‘sex’ × ‘age’ only contributed 
1.5 and 0.5% to the explained variation, respectively, con-
firming that there is no difference between men and 
Table 4.  Meta-analysis results for mean GFR, CKD-EPI and FAS estimation in ml/min/1.73 m2
Age group, years #Studies CKD-EPI FAS Mean mGFR 95% CI
20–30 22/24 114–125 107.3 106.7 104.6–108.9
30–40 22/24 107–117 107.3 104.9 102.8–107.0
40–50 20/24 99–109 95–107 99.0 96.5–101.6
50–60 18/24 93–101 84–95 90.7 88.1–93.3
60–70 14/24 86–95 75–84 84.0 79.5–88.5
>70 6/24 70–88 52–75 69.4 66.1–72.7
 I2 >75% in all age-groups, indicating that high heterogeneity among studies was observed. #Studies = The 
number of studies involved in the meta-analysis for the corresponding age-group (out of 12 × 2 = 24 male/























   
   
   
   
   
   
   
   
   
   






















women in the different age groups. If we replaced ‘study’ 
by ‘method’, the model still explained 88% of the total 
variation in mGFR, with ‘age group’ (59%) and ‘method’ 
(26%) as the only significant variables in the model. In 
this model, no significant interaction terms were ob-
served. This confirms that the measurement method has 
an important effect on the reported mGFR values.
 Publication Bias 
 The danger of unsystematic reviews, with only a por-
tion of relevant studies included, is that they could in-
troduce (publication) bias. One simple way of assessing 
the likely presence of publication bias is to examine a 
funnel plot  [27, 28] . An asymmetric funnel indicates a 
relationship between effect size and precision in the 
Age group 20–30 years
90 95 100 105 110 115 120 125 130
Mean GFR (ml/min/1.73 m2)
Hamilton 2000 males (n = 79)
Hamilton 2000 females (n = 19)
Vervoort 2002 males (n = 11)
Vervoort 2002 females (n = 11)
Hoang 2003 males (n = 55)
Hoang 2003 females (n = 21)
Rule 2004 males (n = 30)
Rule 2004 females (n = 27)
Grewal 2005 males (n = 33)
Grewal 2005 females (n = 13)
Berg 2006 males (n = 12)
Berg 2006 females (n = 12)
Poggio 2009 males (n = 58)
Poggio 2009 females (n = 46)
Peters 2012 males (n = 105)
Peters 2012 females (n = 91)
Blake 2013 males (n = 65)
Blake 2013 females (n = 63)
Soares 2013 males (n = 28)
Soares 2013 females (n = 36)
Holness 2013 males (n = 21)
Holness 2013 females (n = 32)
Total (random-effects) (n = 868)
 Fig. 2. Forest plot for the age group 20–30 years. The vertical black 
line gives the FAS prediction for the mean GFR of 107.3 ml/
min/1.73 m 2 , corresponding to Scr = 0.90 mg/dl for men and 0.70 
mg/dl for women, the median Scr values for healthy Caucasian 
people. The grey-shaded region gives the possible CKD-EPI pre-
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studies at hand. The funnel plots (online suppl. materi-
al) for each age group up to 50 years for the difference 
between men and women were not asymmetric. How-
ever, beyond 50 years, the number of studies rapidly de-
creased and the funnel plots became asymmetric, a sign 
of a possible publication bias or the shift to positive ef-
fect sizes for the studies still present may also indicate a 
more rapid decline of the renal function in women com-
pared to men.
Age group 30–40 years
90 95 100 105 110 115 120 125
Mean GFR (ml/min/1.73 m2)
Hamilton 2000 males (n = 32)
Hamilton 2000 females (n = 12)
Vervoort 2002 males (n = 12)
Vervoort 2002 females (n = 12)
Hoang 2003 males (n = 25)
Hoang 2003 females (n = 14)
Rule 2004 males (n = 56)
Rule 2004 females (n = 55)
Grewal 2005 males (n = 76)
Grewal 2005 females (n = 65)
Berg 2006 males (n = 22)
Berg 2006 females (n = 23)
Poggio 2009 males (n = 120)
Poggio 2009 females (n = 138)
Peters 2012 males (n = 171)
Peters 2012 females (n = 190)
Blake 2013 males (n = 98)
Blake 2013 females (n = 98)
Soares 2013 males (n = 29)
Soares 2013 females (n = 37)
Holness 2013 males (n = 15)
Holness 2013 females (n = 15)
Total (random-effects) (n = 1,315)
 Fig. 3. Forest plot for the age group 30–40 years. The vertical line 
represents the FAS prediction for the mean GFR of 107.3 ml/
min/1.73 m 2 , corresponding to Scr = 0.90 mg/dl for men and 0.70 
mg/dl for women, the median Scr values for healthy Caucasian 
people. The grey-shaded region gives the possible CKD-EPI pre-
dictions (107–117 ml/min/1.73 m 2 ) for this age-group, for the 






















   
   
   
   
   
   
   
   
   
   























 In the current meta-analysis, we confirmed several im-
portant facts regarding normal GFR. First, normal GFR is 
around 107 ml/min/1.73 m 2 , both in men and wom-
en,  until 40 years and at this age, the mean GFR val-
ue tends to decrease progressively. The mean GFR of 107 
ml/min/1.73 m 2 was first suggested by original data ob-
tained by Piepsz et al.  [29, 30]  from children in 2006. 
The  results of our meta-analysis (data from 12 select-
ed articles) confirm that mGFR in adults aged between 
20 and 30 years is well (or at least not different from) 107 
ml/min/1.73 m 2 . For subjects aged between 30 and 40 
years, the mean mGFR was only slightly significantly dif-
Age group 40–50 years
75 80 85 90 95 100 105 110 115 120
Mean GFR (ml/min/1.73 m2)
Hamilton 2000 males (n = 13)
Hamilton 2000 females (n = 15)
Hoang 2003 males (n = 7)
Hoang 2003 females (n = 5)
Rule 2004 males (n = 41)
Rule 2004 females (n = 73)
Grewal 2005 males (n = 44)
Grewal 2005 females (n = 58)
Berg 2006 males (n = 22)
Berg 2006 females (n = 25)
Poggio 2009 males (n = 123)
Poggio 2009 females (n = 165)
Peters 2012 males (n = 245)
Peters 2012 females (n = 349)
Soares 2013 males (n = 28)
Soares 2013 females (n = 37)
Blake 2013 males (n = 163)
Blake 2013 females (n = 154)
Holness 2013 males (n = 17)
Holness 2013 females (n = 17)
Total (random-effects) (n = 1,595)
 Fig. 4. Forest plot for the age group 40–50 years. The grey areas 
give the range of mean GFR values 95–107 predicted by the FAS 
equation and by the CKD-EPI equation 99–109 for this age group, 
for the median Scr values for healthy Caucasian people. The verti-
cal line represents the FAS prediction of 107.3 ml/min/1.73 m 2 up 
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ferent from 107 ml/min/1.73 m 2 but this difference is 
clearly not relevant from a clinical point of view, as the 
mean mGFR was 104.9 ml/min/1.73 m 2 . Moreover, the 
study by Peters et al.  [15] has the largest impact (weight) 
on the meta-analysis results, since this is the study with 
the largest number of subjects, but at the same time, this 
study consistently showed the lowest mean mGFR val-
ues  for all age groups. Without the Peters data, the 
mean  mGFR in the 30–40 years age group becomes 
105.6 with a 95% CI of 103.4–107.8, which includes 107.3 
ml/min/1.73 m 2 . This mean of 107.3 ml/min/1.73 m 2 is 
exactly the GFR value predicted by the FAS equation at 
Age group 50–60 years
60 70 80 90 100 110 120 130
Mean GFR (ml/min/1.73 m2)
Hamilton 2000 males (n = 6)
Hamilton 2000 females (n = 2)
Hoang 2003 males (n = 3)
Hoang 2003 females (n = 8)
Rule 2004 males (n = 20)
Rule 2004 females (n = 39)
Grewal 2005 males (n = 44)
Grewal 2005 females (n = 58)
Berg 2006 males (n = 4)
Berg 2006 females (n = 2)
Poggio 2009 males (n = 85)
Poggio 2009 females (n = 137)
Peters 2012 males (n = 245)
Peters 2012 females (n = 348)
Soares 2013 males (n = 32)
Soares 2013 females (n = 43)
Blake 2013 males (n = 71)
Blake 2013 females (n = 108)
Holness 2013 males (n = 4)
Holness 2013 females (n = 5)
Total (random-effects) (n = 1,264)
 Fig. 5. Forest plot for the age-group 50–60 years. The grey areas 
give the range of mean GFR values 84–95 predicted by the FAS 
equation and by the CKD-EPI equation 93–101 for this age group, 
for the median Scr values for healthy Caucasian people. The verti-
cal line represents the FAS prediction of 107.3 ml/min/1.73 m 2 up 






















   
   
   
   
   
   
   
   
   
   






















Scr = 0.70 mg/dl (women) and Scr = 0.90 mg/dl (men), 
the median Scr values for healthy Caucasian people  [21] . 
These results of the meta-analysis support the construc-
tion of the FAS equation. On the other hand, the mean 
GFR predicted by the CKD-EPI equation for the average 
healthy adult subject (Scr = Q) evolves from 122.5 (men) 
and 125.1 ml/min/1.73 m 2 (women) at the age of 20 years 
to 106.5 (men) and 108.7 ml/min/1.73 m 2 (women) at the 
age of 40 years, a difference of 13%. The high values of 
about 120–125 ml/min/1.73 m 2 at young adult age and 
the decline of about 13% are not supported by the find-
ings of the current meta-analysis results.
Age group 60–70 years
60 70 80 90 100 110 120
Mean GFR (ml/min/1.73 m2)
Hoang 2003 males (n = 10)
Hoang 2003 females (n = 5)
Rule 2004 males (n = 13)
Rule 2004 females (n = 11)
Grewal 2005 males (n = 13)
Grewal 2005 females (n = 24)
Poggio 2009 males (n = 25)
Poggio 2009 females (n = 43)
Peters 2012 males (n = 53)
Peters 2012 females (n = 81)
Soares 2013 males (n = 6)
Soares 2013 females (n = 9)
Blake 2013 males (n = 37)
Blake 2013 females (n = 33)
Total (random-effects) (n = 363)
 Fig. 6. Forest plot for the age group 60–70 years. The grey areas 
give the range of mean GFR values 75–84 predicted by the FAS 
equation and by the CKD-EPI equation 86–95 for this age group, 
for the median Scr values for healthy Caucasian people. The verti-
cal line represents the FAS prediction of 107.3 ml/min/1.73 m 2 up 
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 The second key message of our meta-analysis is that 
mean mGFR is not different between men and women, at 
least not before the age of 50 years  [9, 31], and thus, there 
is no need to build in an extra multiplication factor for 
gender at the GFR level, when the correction for differ-
ences in Scr generation has already been done at the Scr 
level. At this point, we have to comment on the indexation 
by BSA. Indeed, if non-indexed GFR is considered, there 
is an expected difference of mGFR in men and women as 
body size is different according to gender. This point has 
been nicely illustrated in the RENIS cohort study  [31] . 
Also, we and others have criticized the indexation of GFR 
by BSA. If indexation of mGFR is necessary when the GFR 
of one given subject needs to be compared with another 
one, using the BSA is certainly not the best physiological 
tool to index and other authors have proposed other vari-
ables like height or total body water  [22, 31] . However, we 
must admit that indexation by BSA is still the most used, 
both in clinical research and in daily practice. The BSA 
indexation is also included in data sets used to develop 
eGFR equations  [4] . Moreover, the impact of BSA (or the 
errors induced by BSA indexation) will be clinically rele-
vant only in very low and very high BSA values  [22, 31] . 
Because the subjects included from the 12 selected articles 
analyzed in this meta-analysis have normal or near normal 
BSA values, the absence of a difference in normal mGFR 
between men and women can be considered as a good re-
flection of reality. Berg  [14] observed a faster  decline rate 
in men than in women in the age range 20–50 years, but 
not in the years beyond 50 years, which she explained as 
that women seemed to be protected in the pre-menopaus-
al period, probably by estrogens. We did not observe a dif-
ference between men and women up to the age of 50 years, 
and beyond 50 years, the current meta-analysis showed a 
small (3.5 ml/min/1.73 m 2 ) but significant difference be-
tween men and women in the age groups 50–60 and 60–70 
years with a faster decline in women than in men, a finding 
also reported in a Brazilian  [26] and a Chinese population 
 [32] . Women seem to be no longer protected in the post-
menopausal period. Clearly, these contradictory results 
need more investigation.
 From this meta-analysis, we also confirmed data from 
several (but not all) studies suggesting that mGFR pro-
gressively declines from the age of 40 years  [2, 11, 13, 17, 
20, 33] . Indeed, we clearly showed that mGFR is not dif-
ferent in healthy subjects aged between 20 and 30 years on 
one side and between 30 and 40 years on the other side. 
Only after 40 years, the mGFR observed is significantly 
lower than in these youngest. This observation also justi-
fies the mathematical construction of the FAS equation, 
which models the decline in GFR from 40 years on  [21] . 
Indeed, the FAS equation does not predict a decline be-
tween 20 and 40 years. If we use the mean mGFR observed 
in this meta-analysis at the age of 35 years (mGFR  = 
104.9 ml/min/1.73 m 2 ) and at 75 years (mGFR = 69.4 ml/
min/1.73 m 2 ), we can calculate the average mGFR decline. 
The mean GFR decline over this 40-year period is (69.4–
104.9)/40  = –0.89 ml/min/1.73 m 2 /year. Over the same 
period and for mean normal Scr values, the FAS equation 
predicts an average decline rate of (70.3–107.3)/40 = –0.92 
ml/min/1.73 m 2 /year. These results are very close to each 
other, whereas the same calculation with the CKD-EPI 
equation will result in a decline of (83.3–110.3)/40  = 
–0.68 ml/min/1.73 m 2 /year (for men). This larger differ-
ence from the meta-analysis result can be explained by 
the fact that the CKD-EPI equation used a statistical mod-
el with a constant decline rate of GFR with aging over the 
18–75 year age period. The alternative construction of the 
FAS equation shows no age dependency up to 40 years 
and a faster decline rate constant (0.988 age ) beyond that 
age. In other words, the CKD-EPI age term (0.993 age ) has 
to balance the different age decline rates of the 20–40 years 
versus the 40–75 years age range into one overall ‘mean’ 
decline rate factor. The age knot at 40 years is the most 
Table 5.  Meta-analysis results for the mean mGFR and 95% CIs per age group for the different mGFR methods
Age, years 51Cr-EDTA Inulin Iothalamate
20–30 103.0 (101.8–104.2)a 106.2 (103.8–108.6) 110.8 (108.4–113.2)a
30–40 100.8 (99.9–101.8)a, b 105.9 (103.6–108.3)a 107.1 (105.6–108.7)b
40–50 93.9 (93.0–94.7)a, b 101.7 (98.8–104.7)a 103.0 (101.4–104.5)b
50–60 86.9 (86.0–87.8)a 85.0 (83.7–86.4)b 94.6 (92.8–96.5)a, b
60–70 76.8 (75.2–78.4)a 81.0 89.6 (86.4–92.8)a
 a, b Same symbol denotes a statistically significant difference (at row level): for example, for the 20–30 years 






















   
   
   
   
   
   
   
   
   
   






















important difference between the FAS and CKD-EPI 
equations. The current independent meta-analysis sup-
ports the age-knotted form of the FAS equation.
 mGFR can be obtained with different methods  [34] . 
The gold standard method is the urinary clearance of inu-
lin  [2] . This method is however cumbersome and costly 
and other biomarkers like iothalamate, iohexol,  51 Cr- 
EDTA and  99 Tc-DTPA  [34] can be used. Each marker, 
including inulin, can be used in different protocols with or 
without urine collections (i.e., plasma vs. renal clearance) 
 [35] . All the biomarkers and most of the methods can be 
considered as ‘reference method’  [34] . However, the way 
GFR is measured in every single centre is unfortunately 
not standardized. Moreover, it is clear from the literature 
that each method can give slightly different results  [34, 36, 
37] . It is thus not surprising that we found different mGFR 
values according to the reference method considered in 
the present meta-analysis. Compared to inulin results, io-
thalamate clearances give higher mGFR values, which 
may also partially explain the higher estimations by CKD-
EPI (which was developed on iothalamate data). From the 
literature, this result is expected as it has been suggested 
that iothalamate is secreted by renal tubules, leading to a 
slight overestimation of GFR measured by inulin  [34, 38] , 
while results from studies using  51 Cr-EDTA clearances 
give lower mGFR than inulin. Such observation was 
 observed by pioneers in  51 Cr-EDTA like Brochner-
Mortensen  [39] . The differences observed between meth-
ods in the present meta-analysis must be interpreted very 
carefully. Indeed, because of the lack of standardization in 
measuring GFR, differences can be due not only because 
different filtration markers were used but also because of 
the methodology used to calculate GFR: plasma versus re-
nal clearances, choice of sampling times, analytical meth-
ods to measure plasma levels etc.  [34, 35, 37, 40] . The 
number of studies in the current meta-analysis is too low 
to consider all these potential methodological biases.
 There are limitations to our meta-analysis. First, the 
populations concerned in the meta-analysis are, for the 
majority, subject candidates for living kidney donation. 
Sensu stricto, they can be considered as not equivalent to 
the normal general population. Second, the number of 
healthy subjects >65 years remains limited. We clearly 
need additional studies in this specific population. Third, 
we limited our meta-analysis to Caucasians. Some limited 
data from the literature suggest that normal mGFR in 
 African subjects could be the same  [9, 41] but a dedicated 
research in this population would be welcome as data are 
clearly lacking. Limited data are also available from Asian 
populations. Normal mGFR could be slightly lower in 
such Asian populations. Different hypotheses to explain 
such results are lower BSA in this population, low pro-
tein diet or different methods to measure GFR  [1, 32, 42, 
43] . Also in this population, additional research seems 
necessary. Fourth, all the studies included in this meta-
analysis are cross-sectional. Therefore, the mean decline 
in mGFR in ml/min/1.73 m 2 /year described here (–0.89 
ml/min/1.73 m 2 /year between 35 and 75 years), even if 
not very different from few available data in longitudinal 
studies, must be interpreted with caution  [44–46] . Lastly, 
the current meta-analysis does not allow the investigation 
of the Scr dependency in the eGFR equations, which is 
also different between the FAS and CKD-EPI equations.
 In conclusion, the current meta-analysis confirms that 
normal mean mGFR is the same in men and women, be-
low the age of 50 years, is not different from the value of 
107 ml/min/1.73 m 2 proposed from pediatric data up to 
the age of 40 years and starts to decline significantly be-
yond 40 years. This meta-analysis also underlines the ne-
cessity of future research in other ethnicities, in healthy 
subjects >65 years and in a longitudinal design. The re-
sults of the current meta-analysis also support the math-
ematical construction of the new FAS equation recently 
proposed to estimate GFR with a good precision and ac-
curacy from infancy to older age  [21] .
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